Log in to your Inderes Free account to see all free content on this page.

Genovis

19.40 SEK

+2.54%

1,631 following

GENO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genovis

2019202020212022202320242025
Revenue60.561.093.0102.4158.2130.4128.9
growth-%0.8 %52.4 %10.1 %54.5 %-17.6 %-1.1 %
EBITDA13.68.630.314.964.056.233.6
EBIT10.13.124.58.354.245.721.3
Profit before taxes9.72.124.68.054.946.326.8
Net income9.66.424.811.261.532.923.5
EPS0.150.100.380.190.940.500.36
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

2019202020212022202320242025
EBITDA-%22.4 %14.0 %32.6 %14.6 %40.4 %43.1 %26.0 %
EBIT-%16.6 %5.1 %26.4 %8.1 %34.3 %35.1 %16.5 %
ROE26.8 %7.4 %21.7 %8.9 %32.2 %14.4 %8.7 %
ROI19.5 %6.0 %17.5 %7.4 %21.3 %10.1 %6.2 %
Login required

This content is only available for logged in users